Sign in
CompletedNo phase

Safety and Performance of the Journey™ II UNI Unicompartmental Knee System

Key facts

Who runs it
Smith & Nephew, Inc.
Where
Chicago and Rockford, United StatesSee the 2 sitesAlso in 2 other countries, 4 sites
Trial code
Status
Completed
People taking part
154 people enrolled
Started
10 Aug 2018
Ended
19 May 2025
Type of study
Observational
Treatments tested
  • Journey™ II UNI Unicompartmental Knee System
Record updated
27 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Subjects must meet all of the following criteria for inclusion in the study; Unicompartmental, NIDJD, including OA, traumatic arthritis, or avascular necrosis; Eighteen (18) years of age or older at the time of surgery; Skeletally mature in the judgement of the PI; Has met an acceptable preoperative medical clearance and is free of (or acceptably managed) cardiac, pulmonary, hematological, infection, or other conditions that would pose an excessive operative risk; Willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires; Consented to participate in the study by signing the EC-approved ICF

Who cannot take part

  • Subjects meeting any of the following criteria must be excluded from participation in the study; Correction of functional deformity; Revision procedures where other treatments or devices have failed; Treatment of fractures that are unmanageable using other techniques; Inadequate bone stock to support the device which would make the procedure unjustifiable, including but not limited to severe osteopenia/osteoporosis or family history of severe osteoporosis/osteopenia; Body Mass Index (BMI) > 40; Collateral ligament insufficiency; Active infection, treated or untreated, systemic or at the site of the planned surgery or previous intra-articular infections; Incomplete or deficient soft tissue surrounding the knee; Conditions that may interfere with the UKA survival or outcome, including but not limited to Paget's disease, Charcot disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, renal insufficiency or neuromuscular disease; Diagnosis of an immunosuppressive disorder; Known allergy to study device or one or more of its components; Pregnant or planning to become pregnant during the course of the study; Subject, in the opinion of the PI, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation

Where in United States

Also in 2 other countries, 4 sites

  • Rush University Medical CenterChicago, United States
  • OrthoIllinois, LTDRockford, United States

About the trial

What the trial wants to find out

This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will be evaluated.

Treatments tested

  • Journey™ II UNI Unicompartmental Knee System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Multicenter Post-Market Clinical Follow-up Study to Evaluate the Safety and Performance of the Journey™ II UNI Unicompartmental Knee System
Record updated
27 February 2026